Ciplox 0.2%w/v Injection
By Ciplox
Rx
100ml Injection in a Bottle

Composition
Ciprofloxacin(0.2% w/v)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
September, 2025

liver
Ciplox 0.2%w/v Injection is considered safe for patients with liver disease based on the limited available data. It appears that there may not be a need to adjust the dose for these patients. However, it is important to consult your doctor before using Ciplox 0.2%w/v Injection if you have any liver issues. Be sure to inform your doctor if you experience any symptoms of jaundice such as yellowing of the eyes and skin, itching, or clay-colored stools while using this medication.

kidney
Ciplox 0.2%w/v Injection may require dose adjustment for patients with kidney disease. Consult your doctor for guidance.

alcohol
When taking Ciplox 0.2%w/v Injection, it is considered safe to consume alcohol as it does not result in any adverse effects. Safety advice regarding alcohol consumption with Ciplox 0.2%w/v Injection is not necessary.

driving
When taking Ciplox 0.2%w/v Injection, be cautious as it can reduce alertness, affect vision, and cause drowsiness and dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Ciplox 0.2%w/v Injection may not be safe to use during pregnancy. Animal studies suggest harmful effects on the baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor before using Ciplox 0.2%w/v Injection during pregnancy.

breastfeeding
Ciplox 0.2%w/v Injection is considered safe for breastfeeding. Limited data indicates no significant risk to the baby. Monitor the baby for fever, loss of appetite, or diarrhea. Inform your doctor if these symptoms occur.
Habit Forming | No |
Chemical Class | Fluoroquinolone |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Quinolones/ Fluroquinolones |
₹21.69
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025